אוגמנטין  500 מג  זריקות ישראל - עברית - Ministry of Health

אוגמנטין 500 מג זריקות

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

אוגמנטין 1 גרם זריקות ישראל - עברית - Ministry of Health

אוגמנטין 1 גרם זריקות

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 1000 mg; clavulanic acid as potassium clavulanate 200 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

מאקליבן 400 מג  5 מל ישראל - עברית - Ministry of Health

מאקליבן 400 מג 5 מל

novartis israel ltd - amoxicillin as trihydrate; clavulanic acid as potassium - אבקה להכנת תרחיף - amoxicillin as trihydrate 400 mg / 5 ml; clavulanic acid as potassium 57 mg / 5 ml - amoxicillin - amoxicillin - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to amoxycillin + potassium clavulanate and are resistant to other beta-lactam antibiotics.

סינולוקס 250 מג וטרינרי ישראל - עברית - Ministry of Health

סינולוקס 250 מג וטרינרי

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 200 mg; clavulanic acid as potassium 50 mg - amoxicillin

סינולוקס 50 מג וטרינרי ישראל - עברית - Ministry of Health

סינולוקס 50 מג וטרינרי

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 40 mg; clavulanic acid as potassium 10 mg - amoxicillin

אוגמנטין  500 מג  זריקות ישראל - עברית - Ministry of Health

אוגמנטין 500 מג זריקות

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor

אוגמנטין 1 גרם זריקות ישראל - עברית - Ministry of Health

אוגמנטין 1 גרם זריקות

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 1000 mg; clavulanic acid as potassium clavulanate 200 mg - amoxicillin and enzyme inhibitor

סינולוקס LC וטרינרי ישראל - עברית - Ministry of Health

סינולוקס lc וטרינרי

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium; prednisolone - תמיסה לאינפוזיה - amoxicillin as trihydrate 200 mg/dose; clavulanic acid as potassium 50 mg/dose; prednisolone 10 mg/dose - combinations

סינולוקס 500 מג וטרינרי ישראל - עברית - Ministry of Health

סינולוקס 500 מג וטרינרי

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 400 mg; clavulanic acid as potassium 100 mg

טימנטין 3.2 ג' ישראל - עברית - Ministry of Health

טימנטין 3.2 ג'

glaxo smith kline (israel) ltd - clavulanic acid as potassium 200 mg/vial; ticarcillin disodium 3 g/vial - powder for solution for infusion - combinations of penicillins - timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of gram-positive and gram-negative, aerobic and anaerobic bacteria. the presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.